BioMedExperts a Premier Online Scientific Social Network Community

Collexis Holdings, Inc.Dell and Collexis Holdings, Inc., plan to launch today BioMedExperts - an innovative social networking community that will promote collaborative medical research and development. BioMedExperts will allow health care and life sciences professionals to easily connect and collaborate with each other, as well as conduct research by providing 1.4 million biomedical experts with 12 million pre-established network connections from more than 120 countries. The site also provides the ability to analyze all associated professional connections within the network and view scientific publications.

As part of the initiative, Dell will provide computer hardware to power the Collexis-designed BioMedExperts. Dell will also provide marketing support for BioMedExperts, including co-branded marketing efforts and promotions at major life science research conferences.

"Dell believes connecting biomedical scientists through online communities will drive true innovation and progress and is critical to the future of biomedical research. BioMedExperts is a cutting-edge tool that can link researchers from around the globe and enable this new level of collaboration," said James Coffin, Ph.D., vice president and general manager, Dell Health Care and Life Sciences. "The Collexis technology and the BioMedExperts professional community is an example of how technology can connect scientists, enabling them to attack new and more complex cross-disciplinary biological problems. This next-generation professional network platform is a prime example of how Dell works with the world’s most innovative technology companies to drive thought leadership and leading-edge research collaboration."

Bill Kirkland, CEO of Collexis, said, "Collexis is excited about working with an industry leader like Dell, which has an intense focus on success in the life sciences market. We are also delighted to have their support in raising awareness of BioMedExperts among the growing number of biomedical researchers and health care providers who are finding online communities to be a perfect way to share, collaborate and discuss their work and discover new research opportunities. And we see this tool becoming even more valuable to researchers as we add millions of profiles during the next couple of months."

For further information, please visit:
http://www.biomedexperts.com

Related news articles:

About Dell
Dell Inc. (NASDAQ: DELL) listens to customers and delivers innovative technology and services they trust and value. Uniquely enabled by its direct business model, Dell is a leading global systems and services company and No. 34 on the Fortune 500. For more information, visit www.dell.com.

About Collexis Holdings, Inc.
Named a Trend-Setting product of 2007 by KMWorld, Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software since 1999, is headquartered in Columbia, South Carolina (USA), with three subsidiaries: Collexis Inc. in Columbia, South Carolina, USA; Collexis, B.V. in Geldermalsen, The Netherlands; and SyynX Solutions GmBH in Cologne, Germany. Collexis proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, websites, e-mails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’s current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; University of California, San Francisco; University of South Carolina; Erasmus University Library; Merck & Co.; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Collexis shares of common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, please visit www.collexis.com.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...